États-Unis · Places boursières & cours · Nasdaq

Cerenome Unit Signs National Reimbursement Agreement With Aetna; Shares Fall

Publié par Nasdaq · États-Unis il y a 1 h

(RTTNews) - Biotechnology company Cerenome, Inc. (CNSY) announced on Wednesday that its CNSide Diagnostics unit has entered into a national in-network laboratory provider…

Lire l'article complet sur Nasdaq Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.nasdaq.com)

Cerenome Unit Signs National Reimbursement Agreement With Aetna; Shares Fall

À lire aussi

Fire Shuts Equinor’s Visund Platform in Norwegian North Sea

Do you use AI agents to run your daily life? We want to hear about it

Sui Surges 4.93%: Short Squeeze, Technical Buy Signals Drive Rally

Stock Market Today: Dow Jumps More Than 1,000 Points as Major Indexes Surge After Resounding Victory by Democrats in Midterm Elections

Cboe FLEX Options Hit Record Volume in Q3 2026

New capabilities to power agents at scale with Google's Agentic Data Cloud

Cerenome Unit Signs National Reimbursement Agreement With Aetna; Shares Fall

Partager

À lire aussi

Fire Shuts Equinor’s Visund Platform in Norwegian North Sea

Do you use AI agents to run your daily life? We want to hear about it

Sui Surges 4.93%: Short Squeeze, Technical Buy Signals Drive Rally

Stock Market Today: Dow Jumps More Than 1,000 Points as Major Indexes Surge After Resounding Victory by Democrats in Midterm Elections

Cboe FLEX Options Hit Record Volume in Q3 2026

New capabilities to power agents at scale with Google's Agentic Data Cloud